Sofwave™: Lifting Ultrasound to New Levels
Relied on for decades, ultrasound energy is one of the most trusted treatments among top dermatologists, plastic surgeons, and other medical professionals for treating cosmetic concerns. Sofwave taps into this proven technology in a brand new way!
Sofwave is a clinically proven, non-invasive treatment that lifts the skin and reduces fine lines and wrinkles by stimulating collagen and elastin production.
Safe and Effective
Sofwave uses Synchronous Ultrasound Parallel Beam (SUPERB™) technology to generate heat at 1.5 mm in the mid-dermis. This is the optimal depth for remodeling collagen and elastin and lifting the skin. Sofwave also comes with an integrated cooling mechanism, called SofCool™, that protects the outer layer of the skin during treatment, preventing the epidermis from injury.
Patients can immediately return to their normal activities and resume their daily facial care regimen after treatment. Unlike other treatments, Sofwave is unique in that it’s safe for all skin types and can be administered even during the summer months.
- FDA-cleared: lifting the eyebrow
- FDA-cleared: lifting lax submental tissue
- FDA-cleared: lifting neck tissue
- FDA-cleared: improves facial lines and wrinkles.
Innovative Technology with Results
Sofwave results are seen following a single treatment, with improvements in collagen regeneration over the next 12 weeks.
According to clinical studies, 88% of patients report improved or significantly improved appearance of facial wrinkles and necklines 12 weeks after treatment. The best candidate for Sofwave are patients with mild to moderate skin laxity of the face and loose skin under the neck and chin.
The Sofwave Difference
Sofwave is the only device to use Synchronous Ultrasound Parallel Beam technology to boost collagen levels without affecting the skin’s surface. The device’s seven cooled transducers are directly applied to the epidermis, creating a unique 3D array of volumetric thermal zones that deliver parallel energy simultaneously, resulting in significant collagen remodeling in the mid-dermis.
Sofwave Medical Ltd. CEO, Louis Scafuri, says “Sofwave’s technology continues to be enthusiastically received by physicians and consumers. We are continuing to develop new innovative products that will advance the medical aesthetics industry.”